NCT00987766: Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer |
|
|
| Completed | 1 | 28 | US | erlotinib hydrochloride, gemcitabine hydrochloride, oxaliplatin, laboratory biomarker analysis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer, Pancreatic Cancer, Periampullary Adenocarcinoma, Small Intestine Cancer | 07/13 | 10/16 | | |
